Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype

被引:1
|
作者
Gibson, GE
Haroutunian, V
Zhang, H
Park, LCH
Shi, Q
Lesser, M
Mohs, RC
Sheu, RKF
Blass, JP
机构
[1] Cornell Univ, Weill Med Coll, Burke Med Res Inst, Dept Neurol, White Plains, NY 10605 USA
[2] Cornell Univ, Weill Med Coll, Dept Neurosci, White Plains, NY 10605 USA
[3] CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[4] Bronx Vet Affairs Med Ctr, Bronx, NY USA
[5] Northshore Hosp, Manhasset, NY USA
关键词
D O I
10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Brain metabolism and the activity of the alpha -ketoglutarate dehydrogenase complex (KGDHC), a mitochondrial enzyme, are diminished in brains from patients with Alzheimer's disease (AD). In 109 subjects, the Clinical Dementia Rating (CDR) score was highly correlated with brain KGDHC activity. In AD patients who carried the epsilon 4 allele of the apolipoprotein E gene (ApoE4), the CDR score correlated better with KGDHC activity than with the densities of neuritic plaques or neuritic tangles. In contrast, in patients without ApoE4, the CDR score correlated significantly better with tangles and plaques than with KGDHC activity. The results suggest that mitochondrial/oxidative damage may be more important for the cognitive dysfunction in AD patients who early ApoE4 than in those who do not.
引用
收藏
页码:297 / 303
页数:7
相关论文
共 50 条
  • [1] Apolipoprotein E genotype in patients with Alzheimer's disease
    罗本燕
    陈智
    张艳艳
    潘小平
    李霞
    陈峰
    中华医学杂志(英文版), 2003, (08) : 99 - 101
  • [2] Apolipoprotein E genotype and survival in Alzheimer's disease
    DalForno, G
    Carson, K
    Troncoso, J
    Kawas, C
    ANNALS OF NEUROLOGY, 1997, 42 (03) : M33 - M33
  • [3] Apolipoprotein E genotype in patients with Alzheimer's disease
    Luo, BY
    Chen, Z
    Zhang, YY
    Pan, XP
    Li, X
    Chen, F
    CHINESE MEDICAL JOURNAL, 2003, 116 (08) : 1220 - 1222
  • [4] Apolipoprotein E genotype, vitamin E, and Alzheimer's disease prevention
    Huebbe, P.
    Rimbach, G.
    JOURNAL OF APPLIED BOTANY AND FOOD QUALITY, 2008, 82 (01): : 69 - 75
  • [5] Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease
    Levy, ML
    Cummings, JL
    Fairbanks, LA
    Sultzer, DL
    Small, GW
    BIOLOGICAL PSYCHIATRY, 1999, 45 (04) : 422 - 425
  • [6] Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease
    Solfrizzi, V
    Panza, F
    D'Introno, A
    Colacicco, AM
    Capurso, C
    Basile, AM
    Capurso, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (06): : 732 - 736
  • [7] Alzheimer's disease: Clinical implications of the apolipoprotein E genotype
    Farlow, MR
    NEUROLOGY, 1997, 48 (05) : S30 - S34
  • [8] Apolipoprotein E genotype and cognitive symptoms in Alzheimer's disease
    Mehrabian, S.
    Jordanova, A. K.
    Raycheva, M. R.
    Hanon, O.
    Rigaud, A. S.
    Traykov, L. D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 187 - 188
  • [9] Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease
    Mayeux, R
    Saunders, AM
    Shea, S
    Mirra, S
    Evans, D
    Roses, AD
    Hyman, BT
    Crain, B
    Tang, MX
    Phelps, CH
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (08): : 506 - 511
  • [10] Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype
    Ramassamy, C
    Averill, D
    Beffert, U
    Bastianetto, S
    Theroux, L
    Lussier-Cacan, S
    Cohn, JS
    Christen, Y
    Davignon, J
    Quirion, R
    Poirier, J
    FREE RADICAL BIOLOGY AND MEDICINE, 1999, 27 (5-6) : 544 - 553